About this trial
The goal of this observational study is to explore the effect of remimazolam-based total intravenous anesthesia on postoperative neurocognitive function in patients who undergo cardiovascular surgery.
The main question this study tries to answer is: Does remimazolam influence the incidence of postoperative delirium in cardiovascular surgery? Participants already apply remimazolam-based total intravenous anesthesia as part of their regular medical treatment for general anesthesia to perform cardiac surgery will answer questionnaires about cognitive function after surgery.
Eligibility criteria
Qualifiers
Male or female adult patients aged 60 years or older
Receiving elective cardiovascular surgery with cardiopulmonary bypass
Written Informed consent provided
Disqualifiers
Deep hypothermia circulatory arrest
Breastfeeding or pregnancy
Mental or legal disability
Terminal illness with a life expectancy of less than 3 months
Trial design
Treatments tested in this trial
- Not listed